The cell cycle consists of an initial growth phase (G(1)), DNA replication
(S), a gap phase (G(2)), and mitosis (M), after which the cell may differen
tiate or enter the resting state (G(0)). The cycle is driven by a number of
positive and negative regulatory phosphorylation and dephosphorylation eve
nts, involving protein kinases, protein phosphatases, cyclins, cyclin-depen
dent kinases, and cyclin-dependent kinase inhibitors, that ultimately impin
ge on the activity of transcription factors. Unreplicated or damaged DNA bl
ocks the progression of the cell cycle at checkpoints, including a late G(1
) checkpoint regulated by the dephosphorylated retinoblastoma protein and a
late G(2) checkpoint regulated by the phosphorylation of cyclin-dependent
kinase 1 complexed with cyclin B. Many cell cycle regulator genes may be co
nsidered protooncogenes or tumor suppressor genes, and point mutations, amp
lifications, deletions, or rearrangements involving their loci, particularl
y those in the "RB pathway," are associated with various tumors. A number o
f molecular techniques may be used to detect genomic alterations or posttra
nscriptional modifications, but immunohistochemistry remains the most commo
n method to determine expression levels of a regulatory protein. Multivaria
te analysis of the usefulness in prognosis has been applied most often for
the general proliferation antigen Ki-67.